Hormone Replacement Therapy Safe For Women With Menopause and Cancer Survivors

Research shows that short-term hormone replacement therapy (HRT) is appropriate for peri- and postmenopausal women. These and other results from the Women's Health Initiative (WHI), the largest, most statistically valid and well analyzed research evaluating the use of HRT, are reviewed in the International Journal of Gynecological Cancer.

In peri- and postmenopausal women who have moderate to severe vasomotor symptoms associated with estrogen deficiency, data shows that HRT can be beneficial. Although the WHI results only provided data from an oral continuous therapy, researchers say that other routes may be safer and patients should discuss the option with their doctor to weigh the risks against severity of symptoms and expected benefits. Additionally, several studies have shown that the use of HRT in patients who are survivors from gynecologic cancer does not compromise survival, as was previously thought. Several retrospective studies have failed to demonstrate an adverse effect and the establishment of a definitive role for HRT will depend on the analysis of randomized clinical trials. (Source: Blackwell Publishing Ltd: International Journal of Gynecological Cancer: July 2005.)

Related Articles:

• Hormone therapy improves quality of life
• Difficulty sleeping increases as women progress through menopause
• Study finds it pays to be heart smart if considering hormone therapy
• Postmenopausal Hormone Therapy: IMS Updated Recommendations
• Walking, Yoga May Enhance Quality Of Life During Menopause
• Postmenopausal Hormone Therapy Increases Breast Cancer Risk Across All Ethnicities
• Recent Evidence Suggests Caution In Prescribing Hormone Therapy For Breast Cancer And Sheds New Light On 'Menopausal Arthritis'
• Progestogen in HRT may be linked with increased breast cancer risk

Connect

Sign up for free newsletters

Subscribe to RSS feeds

Discuss on Forum

Article Comments

Rate this article